Clinical Trial Update: Reversal of General Anesthesia With Methylphenidate [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating methylphenidate for reversal of general anesthesia in postoperative patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence From Anesthesia
• Postoperative Cognitive Dysfunction

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Post Operative Cognitive Dysfunction, Emergence From Anesthesia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-22